Icahn School of Medicine at Mount Sinai: Prostatic Neoplasms trials

The registry lists 14 Prostatic Neoplasms studies with Icahn School of Medicine at Mount Sinai as lead sponsor. 4 are open to participants now and 4 have results posted.

Phase 1 1Phase 2 5No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active SurveillanceRecruitingNCT07285057Phase 2
• Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate CancerRecruitingNCT07027124Phase 2
• ExosomeDx in MRI-negative Men With High PSANot yet recruitingNCT06966089Not applicable
• Upright MRI for Prostate Cancer ScreeningRecruitingNCT03474913
• CivaSheet With Radical Prostatectomy & Adjuvant External Beam RadiationTerminatedNCT03657108Not applicableResults posted
• A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local TreatmentCompletedNCT03572387Phase 2Results posted
• Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)CompletedNCT02903160Phase 2Results posted
• Abiraterone Acetate Trial in African American Prostate Cancer PatientsTerminatedNCT01735396Phase 2Results posted
• Feasibility of Timesaving When Using Histolog Confocal Laser Endomicroscopy for Margin Assessment in Prostatectomy SpecimenCompletedNCT07141121Not applicable
• Long Acting Neuraxial Peri-prostatic Block in CancerActive, not recruitingNCT06703437Phase 1
• Rectal Spacer Hydrogel Before Radiation Therapy in Reducing Radiation Dose to the Rectum in Patients With Prostate CancerTerminatedNCT05224869Not applicable
• Diversity and Inclusion in Research Underpinning Prevention and Therapy TrialsCompletedNCT05146297Not applicable
• MR/TRUS Fusion Guided Prostate BiopsyStatus unknownNCT04026763Not applicable
• Immune Monitoring on Sipuleucel-TCompletedNCT02237170